Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3389/fimmu.2021.721738 http://scihub22266oqcxt.onion/10.3389/fimmu.2021.721738 34456929!8387963!34456929     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=34456929&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Front+Immunol 2021 ; 12 (?): 721738 Nephropedia Template TP {{tp|p=34456929|t=2021. Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy |pdf=|usr=}}{{34456929}} gab.com Text Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy JO: Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34456929 #FOAvip Here, we described the case of a B cell-deficient patient after CD19 CAR-T cell therapy for refractory B cell Non-Hodgkin Lymphoma with protracted coronavirus disease 2019 (COVID-19). For weeks, this patient only inefficiently contained the virus while convalescent plasma transfusion correlated with virus clearance. Interestingly, following convalescent plasma therapy natural killer cells matured and virus-specific T cells expanded, presumably allowing virus clearance and recovery from the disease. Our findings, thus, suggest that convalescent plasma therapy can activate cellular immune responses to clear SARS-CoV-2 infections. If confirmed in larger clinical studies, these data could be of general importance for the treatment of COVID-19 patients. Twit Text FOAVip Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy ????Front Immunol http://www.kidney.de/pget.php?&tw=1&pmid=34456929 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34456929 #FOAvip English Wikipedia <ref>{{Cite pmid|34456929}}</ref> Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy #MMPMID34456929 Bosnjak B; Odak I; Ritter C; Stahl K; Graalmann T; Steinbruck L; Blasczyk R; Falk CS; Schulz TF; Wedemeyer HH; Cornberg M; Ganser A; Forster R; Koenecke C Front Immunol 2021[]; 12 (?): 721738 PMID34456929show ga Here, we described the case of a B cell-deficient patient after CD19 CAR-T cell therapy for refractory B cell Non-Hodgkin Lymphoma with protracted coronavirus disease 2019 (COVID-19). For weeks, this patient only inefficiently contained the virus while convalescent plasma transfusion correlated with virus clearance. Interestingly, following convalescent plasma therapy natural killer cells matured and virus-specific T cells expanded, presumably allowing virus clearance and recovery from the disease. Our findings, thus, suggest that convalescent plasma therapy can activate cellular immune responses to clear SARS-CoV-2 infections. If confirmed in larger clinical studies, these data could be of general importance for the treatment of COVID-19 patients. |*B-Lymphocytes/immunology[MESH] |*Immunotherapy, Adoptive[MESH] |COVID-19 Serotherapy[MESH] |COVID-19/complications/*immunology/*therapy[MESH] |Female[MESH] |Humans[MESH] |Immunization, Passive[MESH] |Immunoglobulins, Intravenous[MESH] |Immunologic Deficiency Syndromes/complications/*immunology[MESH] |Killer Cells, Natural/*immunology[MESH] |Lymphocyte Activation[MESH] |Lymphopoiesis[MESH] |SARS-CoV-2[MESH] |T-Lymphocytes/*immunology[MESH]Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cel(epmc).pdf DeepDyve Pubget Overpricing